<p>Panel A: Time to Tumor Progression (TTP) in the whole patients' population. Panel B: Median Overall Survival (OS) in the whole patients' population Panel C: Time to Tumor Progression (TTP) in patients with <i>KRAS</i> wt primary tumors. Panel D: Median Overall Survival (OS) in patients with <i>KRAS</i> wt primary tumors.</p
<p>Patients are separated into two groups depending on presence of ERG expression (dashed line) or a...
<p>(a) is a Kaplan-Meier analysis of the overall survival of the four tumor groups in the computatio...
<p>The Kaplan-Meier overall survival curves of two outcome groups classified by MCPHR models using I...
<p>Panel A: Time to Tumor Progression (TTP) in the whole patients' population. Panel B: Median Overa...
<p>Panel A: Time to Tumor Progression (TTP) in the whole patients' population. Panel B: Median Overa...
<p>Panel A: according to <i>PIK3CA</i> mutations status in the whole patients' population. Panel B: ...
<p>(A) OS in all patients stratified by ERCC1 expression. (B) TTF in all patients stratified by ERCC...
<p>Overall survival curves according to ZNF385B mRNA expression level (FC) tertiles (<b>A</b>) and p...
<p>Panel A: Time to Tumor Progression (TTP) according to the worst skin rash grade developed during ...
<p>Median overall survival (mOS) in total 144 advanced and metastasis (stage II–IV) esophageal cance...
Purpose: To study the power of the epidermal growth factor receptor (EGFR) epiregulin (EREG) and amp...
Purpose: To study the power of the epidermal growth factor receptor (EGFR) epiregulin (EREG) and amp...
<p>The patient sample is divided into Low and High (lower and higher expression than median). Panels...
PURPOSE: To study the power of the epidermal growth factor receptor (EGFR) epiregulin (EREG) and amp...
Purpose: To study the power of the epidermal growth factor receptor (EGFR) epiregulin (EREG) and amp...
<p>Patients are separated into two groups depending on presence of ERG expression (dashed line) or a...
<p>(a) is a Kaplan-Meier analysis of the overall survival of the four tumor groups in the computatio...
<p>The Kaplan-Meier overall survival curves of two outcome groups classified by MCPHR models using I...
<p>Panel A: Time to Tumor Progression (TTP) in the whole patients' population. Panel B: Median Overa...
<p>Panel A: Time to Tumor Progression (TTP) in the whole patients' population. Panel B: Median Overa...
<p>Panel A: according to <i>PIK3CA</i> mutations status in the whole patients' population. Panel B: ...
<p>(A) OS in all patients stratified by ERCC1 expression. (B) TTF in all patients stratified by ERCC...
<p>Overall survival curves according to ZNF385B mRNA expression level (FC) tertiles (<b>A</b>) and p...
<p>Panel A: Time to Tumor Progression (TTP) according to the worst skin rash grade developed during ...
<p>Median overall survival (mOS) in total 144 advanced and metastasis (stage II–IV) esophageal cance...
Purpose: To study the power of the epidermal growth factor receptor (EGFR) epiregulin (EREG) and amp...
Purpose: To study the power of the epidermal growth factor receptor (EGFR) epiregulin (EREG) and amp...
<p>The patient sample is divided into Low and High (lower and higher expression than median). Panels...
PURPOSE: To study the power of the epidermal growth factor receptor (EGFR) epiregulin (EREG) and amp...
Purpose: To study the power of the epidermal growth factor receptor (EGFR) epiregulin (EREG) and amp...
<p>Patients are separated into two groups depending on presence of ERG expression (dashed line) or a...
<p>(a) is a Kaplan-Meier analysis of the overall survival of the four tumor groups in the computatio...
<p>The Kaplan-Meier overall survival curves of two outcome groups classified by MCPHR models using I...